ANAVEX Stock Chart Fibonacci Analysis 050423Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 8.15/61.80%
0%
0%
0%
0%
0%
About Anavex Life Sciences Corp
Sector
Health Technology
Industry
Biotechnology
CEO
Christopher U. Missling
Website
anavex.com
Headquarters
New York
Employees
38
Founded
2004
ISIN
US0327973006
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
short to the apex of the triangle target 5.96looking to short this as it retest to the apex of the triangle
FDA Hype Watchlist August 2021In this video I break down my watchlist for potential FDA dates to play in smaller cap pharma companies. Please note that this is not financial advise in any way.
My Watchlist:
$SESN
$FATE
$KLDO
$AVXL
$FSTX
$LPCN
$MITO
Good Luck!
$AVXL is gonna fall todayPupm&Dump trading strategy idea.
$AVXL is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $23,49;
stop-loss — $24,55;
take-profit — $21,37.
Do not view
AVXL Week 12/07/21 - 17/07/21.
It is my first public analysis after having a dozen or so or private and correct analysis. I believe however I need to disclose I am not a financial advisor, however I am a investor in several of AVXL positions and have been studying this stock for a while.
Anyways, in y analysis I came to spot th
2021 - Year of Alzheimer revolution!NASDAQ:AVXL soon new study data will be released which will release the price from the current triangle. PT: 20$ ++
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
